Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


3rd Serialization and Traceability for Brand Protection

09 May 2013 - 10 May 2013 - Philadelphia, PA, USA



Bookmark and Share


ExL Pharma’s 3rd Life Science Serialization and Traceability For Brand Protection is the premier event providing pharmaceutical & life science companies with comprehensive take-back-to-the-office serialization, traceability and e-pedigree strategies.

While there is a continued lack of federal guidance, it is still imperative to make the business case for your organization for brand protection purposes. If the supply chain partners are buttoned up throughout your drug’s journey to the customer, you are adding significant value to your brand by not allowing counterfeit or rogue drugs to damage your reputation.

The 2013 event will challenge the audience with new perspectives, speakers, formats and topics not often seen on the conference circuit, including:

Preparing pharma for California’s 2014/15 serialization mandate.

Learning from other industries:  How The Auto Industry Embraced and Integrated Serialization & Track & Trace

End to End Traceability doesn’t end with the wholesaler: Perspectives from pharmacies, hospitals and consumers on stage.

Top Reasons to Attend

This event prepares pharma for California's 2014 Serialization Mandate.

This event teaches pharma the business case for serialization and traceability in the most pain free and cost effective way

This event provides multiple perspectives throughout the supply chain- pharmacies, manufacturers and wholesalers.



Further information
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!